Earlier immunomodulatory treatment is associated with better visual outcomes in a subset of patients with Vogt-Koyanagi-Harada disease

Author:

Urzua Cristhian A.123,Velasquez Victor12,Sabat Pablo12,Berger Osvaldo4,Ramirez Sebastian2,Goecke Annelise35,Vásquez Darío H.2,Gatica Hector35,Guerrero Julia3

Affiliation:

1. Uveitis Department; Salvador's Hospital; Santiago Chile

2. Ophthalmology Department; University of Chile; Santiago Chile

3. Physiology Program; Faculty of Medicine; University of Chile; Santiago Chile

4. Ophthalmology Department; Catholic University; Santiago Chile

5. Rheumatology Department; University of Chile Clinical Hospital; Santiago Chile

Publisher

Wiley

Subject

Ophthalmology,General Medicine

Reference26 articles.

1. Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high-dose corticosteroids;Abu El-Asrar;Acta Ophthalmol,2013

2. Retention time for corticosteroid-sparing systemic immunosuppressive agents in patients with inflammatory eye disease;Baker;Br J Ophthalmol,2006

3. Vogt-Koyanagi-Harada disease: diagnosis and treatments update;Bordaberry;Curr Opin Ophthalmol,2010

4. Intravitreal triamcinolone acetonide for rebound phenomenon after high-dose intravenous steroid treatment in Vogt-Koyanagi-Harada disease;Byon;Clin Ophthalmol,2011

5. Comparison of the clinical efficacy of two different immunosuppressive regimens in patients with chronic Vogt-Koyanagi-Harada disease;Cuchacovich;Ocul Immunol Inflamm,2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3